Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group. [electronic resource]
Producer: 19970206Description: 251-61 p. digitalISSN:- 0269-2813
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anti-Bacterial Agents -- adverse effects
- Anti-Ulcer Agents -- adverse effects
- Bismuth -- adverse effects
- Clarithromycin -- adverse effects
- Double-Blind Method
- Drug Therapy, Combination
- Duodenal Ulcer -- drug therapy
- Female
- Helicobacter Infections -- drug therapy
- Helicobacter pylori
- Histamine H2 Antagonists -- adverse effects
- Humans
- Male
- Middle Aged
- Patient Compliance
- Ranitidine -- adverse effects
- Recurrence
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.